普洛药业与安帝康生物签署战略合作框架协议

Core Viewpoint - Pro Pharmaceutical (普洛药业) has signed a strategic cooperation framework agreement with Jiaxing Andikang Biotechnology Co., Ltd. (安帝康生物) to enhance long-term collaboration in innovative drug development and strengthen market competitiveness [1] Group 1: Strategic Cooperation - The agreement establishes a strategic partnership between Pro Pharmaceutical and Andikang Biotechnology based on mutual benefits and complementary advantages [1] - The collaboration aims to explore more long-term projects in the field of innovative drugs, enhancing the competitive edge in the pharmaceutical market [1] Group 2: CDMO Business Expansion - The partnership will involve long-term cooperation on CDMO (Contract Development and Manufacturing Organization) projects, which is expected to facilitate the expansion of Pro Pharmaceutical's CDMO business [1] - This collaboration is anticipated to further enhance the competitiveness of the company's CDMO operations [1]